GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Short-Term Debt

Arch Biopartners (TSXV:ARCH) Short-Term Debt : C$4.54 Mil (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Short-Term Debt?

Arch Biopartners's Short-Term Debt for the quarter that ended in Dec. 2023 was C$4.54 Mil.

Arch Biopartners's quarterly Short-Term Debt increased from Jun. 2023 (C$2.10 Mil) to Sep. 2023 (C$4.31 Mil) and increased from Sep. 2023 (C$4.31 Mil) to Dec. 2023 (C$4.54 Mil).

Arch Biopartners's annual Short-Term Debt increased from Sep. 2021 (C$1.80 Mil) to Sep. 2022 (C$2.10 Mil) and increased from Sep. 2022 (C$2.10 Mil) to Sep. 2023 (C$4.31 Mil).

Arch Biopartners Short-Term Debt Historical Data

The historical data trend for Arch Biopartners's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Short-Term Debt Chart

Arch Biopartners Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.80 2.10 4.31

Arch Biopartners Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 3.61 2.10 4.31 4.54

Arch Biopartners Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Arch Biopartners Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Short-Term Debt
Comparable Companies
TSX:ONC TSX:EPRX TSX:SVA XCNQ:ACOG XCNQ:METX TSXV:NGEN TSX:TH TSX:MDNA XCNQ:DTC TSX:MSCL OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Website
https://www.archbiopartners.com
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.